clopidogrel and tamoxifen

clopidogrel has been researched along with tamoxifen in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's9 (81.82)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Dansette, PM; Fontana, E; Poli, SM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Eliasson, E; Mannheimer, B1
Groen, DK; Kitzmiller, JP; Phelps, MA; Sadee, W1
Begg, EJ; Helsby, NA; Jensen, BP1
Kim, RB; Morse, BL1
Molden, E; Solhaug, V1
Arnachellen, D; Augustine, TN; Pillay, K; Xulu, KR1

Reviews

5 review(s) available for clopidogrel and tamoxifen

ArticleYear
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
    Current drug metabolism, 2005, Volume: 6, Issue:5

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Drug-drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice.
    Journal of internal medicine, 2010, Volume: 268, Issue:6

    Topics: Analgesics, Opioid; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents, Hormonal; Biotransformation; Clopidogrel; Codeine; Drug Interactions; Humans; Losartan; Platelet Aggregation Inhibitors; Tamoxifen; Ticlopidine

2010
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.
    Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:4

    Topics: Clopidogrel; Cytochrome P-450 Enzyme System; Genetic Testing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacogenetics; Psychotropic Drugs; Tamoxifen; Ticlopidine; Warfarin

2011
Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis.
    Pharmacogenomics, 2012, Volume: 13, Issue:1

    Topics: Aryl Hydrocarbon Hydroxylases; Azathioprine; Camptothecin; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Enzymes; Glucuronosyltransferase; Humans; Inactivation, Metabolic; Irinotecan; Methyltransferases; Mixed Function Oxygenases; Prodrugs; Tamoxifen; Ticlopidine; Vitamin K Epoxide Reductases; Warfarin

2012

Other Studies

6 other study(ies) available for clopidogrel and tamoxifen

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Glutathione; Pharmacology; Sulfur Radioisotopes

2011
[Individualized medicine. DNA tests for better treatment safety].
    MMW Fortschritte der Medizin, 2014, May-15, Volume: 156, Issue:9

    Topics: Antidepressive Agents; Biotransformation; Clopidogrel; Dose-Response Relationship, Drug; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Clearance Rate; Precision Medicine; Sequence Analysis, DNA; Tamoxifen; Ticlopidine; Treatment Outcome

2014
Is personalized medicine a dream or a reality?
    Critical reviews in clinical laboratory sciences, 2015, Volume: 52, Issue:1

    Topics: Clopidogrel; Drug Therapy; Genetic Variation; Genomics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacokinetics; Precision Medicine; Tamoxifen; Ticlopidine; Warfarin

2015
[Genetically determined variation in bioactivation of tamoxifen and clopidogrel].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016, Mar-15, Volume: 136, Issue:5

    Topics: Antineoplastic Agents; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Genetic Variation; Genotype; Humans; Tamoxifen; Ticlopidine

2016
Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail.
    Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada, 2023, 06-09, Volume: 29, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Agents; Aspirin; Breast Neoplasms; Clopidogrel; Female; Humans; Mammary Neoplasms, Animal; Nitriles; Tamoxifen; Triazoles

2023